These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 8420542
1. Hypercalcemia of malignancy: pathophysiology and implications for treatment. Theriault RL. Oncology (Williston Park); 1993 Jan; 7(1):47-50; discussion 52-5. PubMed ID: 8420542 [Abstract] [Full Text] [Related]
2. Pathophysiology and management of severe hypercalcemia. Nussbaum SR. Endocrinol Metab Clin North Am; 1993 Jun; 22(2):343-62. PubMed ID: 8325291 [Abstract] [Full Text] [Related]
3. Management of hypercalcemia in breast cancer. Theriault RL. Oncology (Williston Park); 1990 Feb; 4(2):43-6; discussion 50. PubMed ID: 2143669 [Abstract] [Full Text] [Related]
4. Hypercalcemia and bone resorption in malignancy. Walls J, Bundred N, Howell A. Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618 [Abstract] [Full Text] [Related]
5. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy. Kovacs CS, MacDonald SM, Chik CL, Bruera E. J Pain Symptom Manage; 1995 Apr; 10(3):224-32. PubMed ID: 7543127 [Abstract] [Full Text] [Related]
6. Mechanisms and treatment of hypercalcemia of malignancy. Clines GA. Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221 [Abstract] [Full Text] [Related]
7. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease. Kanakis I, Kousidou OCh, Karamanos NK. In Vivo; 2005 Dec; 19(1):311-8. PubMed ID: 15796191 [Abstract] [Full Text] [Related]
9. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm. McMahan J, Linneman T. Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757 [Abstract] [Full Text] [Related]
10. Mechanisms and treatment for bone metastases. Clines GA, Guise TA. Clin Adv Hematol Oncol; 2004 May; 2(5):295-302. PubMed ID: 16163196 [Abstract] [Full Text] [Related]
11. Cancer-induced hypercalcemia. Lumachi F, Brunello A, Roma A, Basso U. Anticancer Res; 2009 May; 29(5):1551-5. PubMed ID: 19443365 [Abstract] [Full Text] [Related]
12. Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors. Rosen LS. Semin Oncol; 2002 Dec; 29(6 Suppl 21):28-32. PubMed ID: 12584692 [Abstract] [Full Text] [Related]
16. [Hypercalcemia in malignant diseases. Physiopathology and treatment]. Aasarød K, Lamvik J. Tidsskr Nor Laegeforen; 1989 Apr 30; 109(12):1293-6. PubMed ID: 2734758 [Abstract] [Full Text] [Related]
17. Treating cancer-related hypercalcemia with gallium nitrate. Leyland-Jones B. J Support Oncol; 2004 Apr 30; 2(6):509-16. PubMed ID: 15605917 [Abstract] [Full Text] [Related]
18. [Refractory hypercalcemia in patient with lung cancer]. Grzywacz A, Dziuk M, Niemczyk S. Pol Merkur Lekarski; 2014 Apr 30; 36(214):261-4. PubMed ID: 24868900 [Abstract] [Full Text] [Related]
19. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy. Kawada K, Minami H, Okabe K, Watanabe T, Inoue K, Sawamura M, Yagi Y, Sasaki T, Takashima S. Jpn J Clin Oncol; 2005 Jan 30; 35(1):28-33. PubMed ID: 15681601 [Abstract] [Full Text] [Related]
20. A practical approach to hypercalcemia. Carroll MF, Schade DS. Am Fam Physician; 2003 May 01; 67(9):1959-66. PubMed ID: 12751658 [Abstract] [Full Text] [Related] Page: [Next] [New Search]